Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Colorcon
Covington
Healthtrust
Mallinckrodt
Dow
Fish and Richardson
Queensland Health
Cipla

Generated: December 12, 2017

DrugPatentWatch Database Preview

Avanthi Inc Company Profile

« Back to Dashboard

What is the competitive landscape for AVANTHI INC, and what generic and branded alternatives to AVANTHI INC drugs are available?

AVANTHI INC has ten approved drugs.



Summary for Avanthi Inc

US Patents:0
Tradenames:9
Ingredients:9
NDAs:10
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Avanthi IncDEXTROAMPHETAMINE SULFATEdextroamphetamine sulfateTABLET;ORAL203548-002Nov 23, 2015AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Avanthi IncOXYCODONE HYDROCHLORIDEoxycodone hydrochlorideCAPSULE;ORAL202773-001Aug 17, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Avanthi IncLOMAIRAphentermine hydrochlorideTABLET;ORAL203495-001Sep 12, 2016RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Avanthi IncCHLORPHENIRAMINE MALEATEchlorpheniramine maleateTABLET, EXTENDED RELEASE;ORAL040829-001May 13, 2009OTCNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Avanthi IncOXYCODONE HYDROCHLORIDEoxycodone hydrochlorideTABLET;ORAL091393-004Aug 31, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Avanthi IncOXYCODONE HYDROCHLORIDEoxycodone hydrochlorideTABLET;ORAL091393-003Aug 31, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Avanthi IncOXYMORPHONE HYDROCHLORIDEoxymorphone hydrochlorideTABLET;ORAL203601-002Jan 30, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Avanthi IncINDOMETHACINindomethacinCAPSULE, EXTENDED RELEASE;ORAL079175-001Mar 6, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Avanthi IncOXYCODONE HYDROCHLORIDEoxycodone hydrochlorideTABLET;ORAL091393-005Aug 31, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Avanthi IncDEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATEdexbrompheniramine maleate; pseudoephedrine sulfateTABLET, EXTENDED RELEASE;ORAL078648-001Feb 27, 2013OTCNoYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Cerilliant
McKinsey
US Army
Baxter
Citi
UBS
Queensland Health
Johnson and Johnson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot